使用英夫利昔单抗治疗白塞病性葡萄膜炎一年后出现获得性耐药。 - Suppr

Acquired resistance to infliximab against uveitis due to Behçet's disease after one year of administration.

作者信息

Ito Takako, Sonoda Koh-Hei, Hijioka Kuniaki, Fujimoto Takeshi, Ishibashi Tatsuro

出版信息

Jpn J Ophthalmol. 2010 Sep;54(5):502-4. doi: 10.1007/s10384-010-0859-0. Epub 2010 Nov 5.

DOI:10.1007/s10384-010-0859-0

PMID:21052918

Abstract

摘要

相似文献

Acquired resistance to infliximab against uveitis due to Behçet's disease after one year of administration.

Jpn J Ophthalmol. 2010 Sep;54(5):502-4. doi: 10.1007/s10384-010-0859-0. Epub 2010 Nov 5.

Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S93. Epub 2011 Sep 27.

Efficacy of infliximab on the acute attack of uveitis.

Saudi Med J. 2010 Jan;31(1):82-5.

[Infliximab treatment for Behçet's disease--beginning of the biological drug era].

Nippon Ganka Gakkai Zasshi. 2010 Feb;114(2):85-6.

Cataract surgery under infliximab therapy in a patient with Behçet's disease.

J Ocul Pharmacol Ther. 2009 Oct;25(5):467-70. doi: 10.1089/jop.2009.0054.

Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.

Rheumatology (Oxford). 2014 Dec;53(12):2223-31. doi: 10.1093/rheumatology/keu266. Epub 2014 Jul 4.

Adalimumab for sight-threatening uveitis in Behçet's disease.

Eye (Lond). 2007 Jun;21(6):824-5. doi: 10.1038/sj.eye.6702352. Epub 2006 Apr 7.

Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.

Ophthalmology. 2014 Oct;121(10):1877-84. doi: 10.1016/j.ophtha.2014.04.042. Epub 2014 Jun 18.

Long-term remission of ocular and extraocular manifestations in Behçet's disease using infliximab.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S58-63. Epub 2011 Sep 27.

The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease.

Adv Exp Med Biol. 2003;528:557-9. doi: 10.1007/0-306-48382-3_112.

引用本文的文献

Treatment Options in Pediatric Behçet's Disease.

Paediatr Drugs. 2023 Mar;25(2):165-191. doi: 10.1007/s40272-022-00548-5. Epub 2023 Jan 10.

Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet's disease.

Eur J Rheumatol. 2018 Mar;5(1):9-15. doi: 10.5152/eurjrheum.2017.17068.

Long-term efficacy of infliximab on background vascular leakage in patients with Behçet's disease.

Eye (Lond). 2014 Sep;28(9):1100-6. doi: 10.1038/eye.2014.138. Epub 2014 Jun 20.

Psoriasis triggered by infliximab in a patient with Behçet's disease.

Jpn J Ophthalmol. 2013 Jan;57(1):95-7. doi: 10.1007/s10384-012-0198-4. Epub 2012 Oct 23.

本文引用的文献

Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study.

Mod Rheumatol. 2009;19(5):478-87. doi: 10.1007/s10165-009-0195-8. Epub 2009 Jul 22.

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.

J Rheumatol. 2004 Jul;31(7):1362-8.

Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial.

Gastroenterology. 2003 Apr;124(4):917-24. doi: 10.1053/gast.2003.50145.

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

N Engl J Med. 2000 Nov 30;343(22):1594-602. doi: 10.1056/NEJM200011303432202.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Acquired resistance to infliximab against uveitis due to Behçet's disease after one year of administration.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献